Norges Bank Rhythm Pharmaceuticals, Inc. Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Norges Bank holds 43,238 shares of RYTM stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,238

Holding current value

$2.22 Million

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $1.53 Million - $1.92 Million	43,238 New	43,238 $1.78 Million
Q1 2022 May 09, 2022	SELL	$6.13 - $12.24 $313,616 - $626,210	-51,161 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$8.62 - $13.9 $441,007 - $711,137	51,161 New	51,161 $511,000
Q3 2021 Nov 14, 2022	BUY	$11.68 - $20.72 $597,560 - $1.06 Million	51,161 New	51,161 $668,000
Q3 2021 Nov 05, 2021	SELL	$11.68 - $20.72 $597,560 - $1.06 Million	-51,161 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$18.52 - $22.55 $947,501 - $1.15 Million	51,161 New	51,161 $1 Million
Q2 2021 Aug 10, 2021	SELL	$18.52 - $22.55 $1.21 Million - $1.47 Million	-65,108 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$20.25 - $39.49 $1.32 Million - $2.57 Million	65,108 New	65,108 $1.39 Million
Q1 2021 May 07, 2021	SELL	$20.25 - $39.49 $3.23 Million - $6.3 Million	-159,428 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$21.17 - $32.61 $3.38 Million - $5.2 Million	159,428 New	159,428 $4.74 Million
Q4 2020 Feb 10, 2021	SELL	$21.17 - $32.61 $3.38 Million - $5.2 Million	-159,428 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$18.13 - $30.61 $2.89 Million - $4.88 Million	159,428 New	159,428 $3.46 Million
Q3 2020 Nov 10, 2020	SELL	$18.13 - $30.61 $4.17 Million - $7.05 Million	-230,195 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$14.41 - $25.35 $3.32 Million - $5.84 Million	230,195 New	230,195 $5.13 Million
Q2 2020 Aug 07, 2020	SELL	$14.41 - $25.35 $3.32 Million - $5.84 Million	-230,195 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$13.16 - $22.9 $3.03 Million - $5.27 Million	230,195 New	230,195 $3.5 Million
Q1 2020 May 08, 2020	SELL	$13.16 - $22.9 $3.03 Million - $5.27 Million	-230,195 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$19.53 - $25.5 $4.5 Million - $5.87 Million	230,195 New	230,195 $5.29 Million
Q3 2018 Nov 09, 2018	SELL	$26.99 - $35.85 $809,700 - $1.08 Million	-30,000 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$17.02 - $35.2 $510,600 - $1.06 Million	30,000 New	30,000 $938,000
Q2 2018 Jul 23, 2018	SELL	$17.02 - $35.2 $851,000 - $1.76 Million	-50,000 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$19.9 - $32.25 $994,999 - $1.61 Million	50,000 New	50,000 $995,000
Q1 2018 May 09, 2018	SELL	$19.9 - $32.25 $994,999 - $1.61 Million	-50,000 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$22.0 - $30.51 $1.1 Million - $1.53 Million	50,000	50,000 $1.45 Million

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

Primecap Management CO Pasadena, CA

7.31M
Shares

$375 Million
0.22% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$346 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$329 Million
3.49% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$312 Million
3.77% of portfolio
Goldman Sachs Group Inc New York, NY

5.29M
Shares

$272 Million
0.04% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account